NASDAQ:BVS | Free Cash Flow | Bioventus Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2019-12-31 to 2026-03-28
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-28$8.93M$574,000.00$8.36M268.55%
2025-12-31$37.97M$580,000.00$37.39M253.39%
2025-03-29-$19.33M$826,000.00-$20.16M
2024-12-31$19.32M$574,000.00$18.75M
2024-03-30-$6.01M$291,000.00-$6.3M
2023-12-31$10.37M$369,000.00$10.01M
2023-04-01$2.49M$3.56M-$1.07M
2022-12-31$5.24M-$5.16M$83,000.00
2022-04-02-$21.02M$2.96M-$23.98M
2021-12-31$13.12M$8.95M$4.17M
2021-04-03-$18.04M$1.37M-$19.41M-77.85%
2020-12-31$25.45M$14.25M$11.2M403.42%
2020-03-28$17.69M$299,000.00$17.39M158.92%

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31$74.67M$2.56M$72.11M317.22%
2024-12-31$38.8M$1.01M$37.79M
2023-12-31$15.34M$7.36M$7.98M
2022-12-31-$13.54M$1.48M-$15.02M
2021-12-31$22.99M$13.52M$9.47M48.88%
2020-12-31$71.8M$16.58M$55.22M336.48%
2019-12-31$40.71M$2.34M$38.37M560.08%